These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26693623)

  • 1. Factors Associated with Erosive Arthritis in Rheumatoid Arthritis and Other Connective Tissue Diseases: A Retrospective Study From a Southern Chinese Population.
    Yuan S; Chen D; Xiao Y; Lao M; Qiu Q; Liang L; Yang X
    J Clin Rheumatol; 2016 Jan; 22(1):22-9. PubMed ID: 26693623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
    Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
    Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage System.
    Martin L; Steber WA; Lupton TL; Mahler M; Fitch CM; McMillan JD; Schmidt DR; Fritzler MJ
    J Rheumatol; 2015 May; 42(5):771-7. PubMed ID: 25641884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
    Nakabo S; Yoshifuji H; Hashimoto M; Imura Y; Nakashima R; Murakami K; Kuramoto N; Ito S; Satoh J; Tanaka M; Fujii T; Mimori T; Ohmura K
    J Rheumatol; 2017 Sep; 44(9):1384-1388. PubMed ID: 28507178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis.
    Stamenković B; Stanković A; Dimić A; Damjanov N; Nedović J; Stojanović S; Savić V; Djordjević D
    Srp Arh Celok Lek; 2012; 140(5-6):350-4. PubMed ID: 22826990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
    Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
    J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study.
    Nell-Duxneuner V; Machold K; Stamm T; Eberl G; Heinzl H; Hoefler E; Smolen JS; Steiner G
    Ann Rheum Dis; 2010 Jan; 69(1):169-74. PubMed ID: 19153104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis.
    Shankar S; Grover R; Handa R
    Indian J Med Res; 2006 Dec; 124(6):689-96. PubMed ID: 17287557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T; Feng L
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deforming Arthropathy in Thai Patients With Systemic Lupus Erythematosus.
    Lhakum P; Kasitanon N; Sivasomboon C; Wangkaew S; Louthrenoo W
    J Clin Rheumatol; 2016 Jan; 22(1):1-7. PubMed ID: 26693619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related diagnostic utility of rheumatoid factor, anticyclic citrullinated peptide and antikeratin antibodies in Chinese patients with rheumatoid arthritis.
    Lin J; Liu C; Yang B; Ou Q
    J Int Med Res; 2014 Jun; 42(3):711-7. PubMed ID: 24764355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
    Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
    Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.